Trials / Completed
CompletedNCT00753558
Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae
A Randomized,Double-Blind,Placebo-Controled Trial of Selective Digestive Decontamination Using Oral Gentamicin and Oral Polymyxin E for Eradication of Carbapenem-Resistant Klebsiella Pneumoniae Carriage
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Soroka University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There is an urgent need to control our current national outbreak of carbapenem-resistant Klebsiella pneumoniae (CRKP). The purpose of this study is to eradicate CRKP gastrointestinal carriage using selective digestive decontamination (SDD); with buccal and oral gentamicin and polymyxin E administration. This will reduce infections and hopefully mortality caused by CRKP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Arm #1 :Oral solution and buccal gel of gentamicin and polymyxin E. Arm #2: Placebo. | Arm #1: Oral gentamicin \& polymyxin E, gentamicin \& polymyxin E buccal gel. Arm #2: Oral placebo solutions, placebo buccal gel. |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-06-01
- Completion
- 2010-07-01
- First posted
- 2008-09-16
- Last updated
- 2010-09-21
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00753558. Inclusion in this directory is not an endorsement.